Drug Information Association Logo
Corporate Tagline

DIA to Host Marketing Pharmaceuticals 2013: How to Market in a Highly Regulated Environment

WASHINGTON — February 15, 2013

DIA will host its 24th annual meeting on marketing pharmaceuticals -- Marketing Pharmaceuticals 2013 --  at the Grand Hyatt in Washington, DC, February 20-21. The two days will bring together thought leaders from regulators to industry executives – all experts who will provide timely, practical and vital information on how to legally, effectively and efficiently navigate an ever-changing regulated environment.

“The costs of non-compliance can be enormous, making the information we will be disseminating at this conference hugely important to the industry.  We are excited that year in and year out – now for 24 years -- the experts at our meeting provide timely and up to the minute information that provide the tools companies need to prepare compliant marketing strategies,” said Susan Cantrell, Director, North America at DIA.

As a result of the high-level speakers, the depth and breadth of the information that will be available is unparalleled. Speakers will include, but are not limited to:

  • Wayne L. Pines, President, Regulatory Services and Healthcare, APCO Worldwide, Inc.
  • Lisa L. Stockbridge, PhD, Branch Chief, Advertising and Promotional Labeling Branch, CBER, FDA
  • Thomas W. Abrams, MBA, RPh, Director, Office of Prescription Drug Promotion (OPDP) CDER, FDA
  • Glenn N. Byrd, MBA, RAC, Senior Director, Regulatory Affairs, MedImmune, LLC
  • Michele Hardy, Vice President, Regulatory Advertising and Promotion Policy, GlaxoSmithKline
  • Leah Palmer, PharmD, Executive Director, Regulatory Promotion, Amgen Inc.

With sessions ranging from "Fundamental Issues in the Regulatory Evaluation of Health Economic Information" to "Social Media: Digital Tools and Considerations in Compliant Development" to "FDA Guidance Update" to "Recent Updates and Future Trends in Corporate Integrity Agreements and Compliance Programs," the agenda will prove to be of great importance to regulatory, legal, communications professionals, and promotional review teams.

 

 

 

 

###

ABOUT DIA: DIA is the global connector in the life sciences product development process. Our association of more than 18,000 members builds productive relationships by bringing together regulators, innovators and influencers to exchange knowledge and collaborate in an impartial setting. DIA’s network creates unparalleled opportunities for the exchange of knowledge and has the interdisciplinary experience to prepare for future developments. The dedicated efforts of DIA staff, members and speakers enable DIA to provide a comprehensive catalogue of conferences, workshops, training courses, scientific publications and educational materials. DIA is a global community representing thousands of stakeholders working together to bring safe and effective products to patients. DIA is an independent, nonprofit organization with its global center in Washington, D.C., USA; regional offices covering North and South America (Horsham, Penn., USA); Europe, North Africa and the Middle East (Basel, Switzerland); and Japan (Tokyo), India (Mumbai) and China (Beijing). For more information, visit www.diahome.org.